Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Lenka Jakubíková"'
Publikováno v:
Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti. 35(3)
The pandemic of COVID-19 has significantly influenced the dia-gnostics and treatment of patients with lung and pleural malignancies. This group of patients is the riskiest, compared to patients with other cancers, both in morbidity and mortality.The
Autor:
Lenka Jakubíková
Publikováno v:
Klinicka Onkologie. 33:302-308
Carcinoids have been classified according to their embryonic origin in the past and are now categorized and classified as neuroendocrine tumors, including low malignant typical carcinoids, moderate malignant atypical carcinoids, and highly malignant
Autor:
Marketa Cernovska, Gunta Purkalne, Jelena Spasic, Virag Hollosi, Lenka Jakubíková, Krisztina Bogos, Katerina Fröhlich, Dragana Jovanovic, Leona Koubková, Jirí Kufa, Andreas Tiefenbacher, Zdenka Vilasova, Vesna Ceriman, Subhash Chaudhary, Juraj Kultan, Attila Farkas, Zuzana Zbozinkova, Mirjana Rajer, Robert Pirker, Jiri Votruba, Marius Zemaitis, Lubos Petruzelka, Iveta Kolarova, Milada Zemanova, Karin Dieckmann, Igor Richter
Publikováno v:
Radiology and Oncology, Vol 54, Iss 2, Pp 209-220 (2020)
Radiology and Oncology
Radiology and Oncology
Background Management of non-small-cell lung cancer (NSCLC) is affected by regional specificities. The present study aimed at determining diagnostic and therapeutic procedures including outcome of patients with NSCLC stage III in the real-world setti
Autor:
Magda Barinova, Bohuslav Melichar, Karolina Hurdalkova, Martin Svaton, Jiri Blazek, Lenka Jakubíková, M. Černovská, Michal Jirousek, Daniel Krejci, Jana Skrickova, Milada Zemanova, J. Krejčí, Petra Zemanova, Michal Hrnčiarik, Ondrej Bilek, Ondrej Fischer, Juraj Kultan
Publikováno v:
Anticancer Research. 40:2209-2217
To investigate potential association between administration of corticosteroids, antibiotics, probiotics, proton pump inhibitors, non-steroidal anti-inflammatory drugs (NSAID), statins and metformin and outcome in patients with non-small cell lung can
Autor:
Martin Svaton, Renata Chloupková, Lenka Jakubíková, Milada Zemanova, Juraj Kultan, František Salajka, Bohuslav Melichar, Vitezslav Kolek, Alzbeta Bejckova, Marek Konecny, Michal Hrnčiarik, Leona Koubková, Jana Skrickova, Miloš Pešek, David Vrána
Publikováno v:
Anticancer Research. 38:6771-6782
Aim To investigate potential associations between clinical and standard peripheral blood biomarkers and clinical outcome in patients with non-small cell lung cancer (NSCLC) treated with nivolumab. Patients and methods A total of 120 patients with adv
Autor:
Lenka Jakubíková, Jana Skřičková, Jana Špeldová, Marcela Tomíšková, Ondřej Venclíček, Bohdan Kadlec, Blanka Robešová, Zdeněk Merta
Publikováno v:
Onkologie. 12:175-181
Při lecebne rozvaze po stanoveni diagnozy je v soucasnosti snahou vybrat pro nemocneho s nemalobuněcným karcinomem (NSCLC) lek, u ktereho je prokazano, že je ucinný u nadoru, který nese urcite morfologicke a/nebo molekularně geneticke znaky. N
Publikováno v:
Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti. 33(3)
Malignant tumours of the trachea, the lungs, and the bronchus are the second most common type of tumour in the Czech Republic. Approximately three-quarters of cases are dia-gnosed in an advanced stage (IIIB-IV) and are one of the most common causes o
Autor:
Zdeňka Vilasová, Marketa Cernovska, Gunta Purkalne, Jiří Kufa, Attila Farkas, Jelena Spasic, Marius Zemaitis, Vesna Ceriman, Robert Pirker, Lenka Jakubíková, Milada Zemanova, Karin Dieckmann, Dragana Jovanovic, Leona Koubková, Igor Richter, Luboš Petruželka, Virag Hollosi, Subhash Chaudhary, Zuzana Zbožínková, Andreas Tiefenbacher, Miroslaw Kozlowski, Krisztina Bogos
Publikováno v:
Journal of Thoracic Oncology. 12:S852-S853